Clinical Trial Update: Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure [Phase 4]

View source ↗

Summary

Phase 4 pediatric Crohn's disease trial evaluating two immunomodulator withdrawal schemes in infliximab monotherapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Prof. Arie Levine | Conditions: Crohn's Disease | Phase 4 | Status: TERMINATED